Clinical Trial Update: Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of Utidelone as monotherapy for advanced solid tumors, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gastric Cancer
• Ovarian Cancer

Drugs mentioned

• Utidelone (utidelone)

Snippet

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. | Conditions: Gastric Cancer Adenocarcinoma Metastatic, Ovarian Cancer | Phase 2 | Status: NOT_YET_RECRUITING